Vital Therapies (VTL) Priced

Developing bio-artificial liver cells for the treatment of acute liver failure.

Health Care - Biotechnology

IPO Performance
Latest Trade $4.60 0.00 (0.0%)
First Day Return 0.0%
Return from IPO -61.7%
 
Vital Therapies IPO News more
  • .
IPO Data
IPO File Date 10/11/2013
Offer Price $12.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.5
Deal Size ($mm) 54
 
IPO Data
IPO Date 04/16/2014
Offer Price $12.00
Price Range $13.00 - $15.00
Offer Shares (mm) 4.5
Deal Size ($mm) $54
 
Underwriters
more
Business Overview
Developing bio-artificial liver cells for the treatment of acute liver failure.
Developing bio-artificial liver cells for the treatment of acute liver failure.
more
Company Data
Headquarters San Diego, CA
Founded 2003
Employees 70
Website www.vitaltherapies.com
 

Performance vs. IPO Index (IPOUSA)